Diagnostic Enzymes Market (By Type; By Application: Oncology, Diabetes, Infectious Diseases, Cardiology, Autoimmune Diseases, Nephrology, Others; By Product Type: Clinical Enzymes, Molecular Enzymes) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Diagnostic Enzymes Market 

5.1. COVID-19 Landscape: Diagnostic Enzymes Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Diagnostic Enzymes Market, By Type

8.1. Diagnostic Enzymes Market, by Type, 2022-2032

8.1.1 MMLV RT

8.1.1.1. Market Revenue and Forecast (2022-2032)

8.1.2. Taq Polymerase

8.1.2.1. Market Revenue and Forecast (2022-2032)

8.1.3. Hot Start Taq Polymerase

8.1.3.1. Market Revenue and Forecast (2022-2032)

8.1.4. HIV RT

8.1.4.1. Market Revenue and Forecast (2022-2032)

8.1.5. RNase Inhibitors

8.1.5.1. Market Revenue and Forecast (2022-2032)

8.1.6. UNG

8.1.6.1. Market Revenue and Forecast (2022-2032)

8.1.7. PCR Master Mix

8.1.7.1. Market Revenue and Forecast (2022-2032)

8.1.8. Bst Polymerase

8.1.8.1. Market Revenue and Forecast (2022-2032)

8.1.9. T7 RNA Polymerase

8.1.9.1. Market Revenue and Forecast (2022-2032)

8.1.10. Lyophilized Polymerase

8.1.10.1. Market Revenue and Forecast (2022-2032)

8.1.11. Acid Phosphatase

8.1.11.1. Market Revenue and Forecast (2022-2032)

8.1.12. Cas9 Enzyme

8.1.12.1. Market Revenue and Forecast (2022-2032)

8.1.13. Amylase

8.1.13.1. Market Revenue and Forecast (2022-2032)

8.1.14. Alanine Aminotransferase

8.1.14.1. Market Revenue and Forecast (2022-2032)

8.1.15. Others

8.1.16.1. Market Revenue and Forecast (2022-2032)

8.1.16. Aspartate Aminotransferase

8.1.16.1. Market Revenue and Forecast (2022-2032)

8.1.17. Angiotensin Converting Enzyme

8.1.17.1. Market Revenue and Forecast (2022-2032)

8.1.18. Creatinine Kinase

8.1.18.1. Market Revenue and Forecast (2022-2032)

8.1.19. Cholinesterase

8.1.19.1. Market Revenue and Forecast (2022-2032)

8.1.20. Lactate Dehydrogenase

8.1.20.1. Market Revenue and Forecast (2022-2032)

8.1.21. Gamma GlutamylTransferase

8.1.21.1. Market Revenue and Forecast (2022-2032)

8.1.22. Glucose Oxidase/Glucose Dehydrogenase

8.1.22.1. Market Revenue and Forecast (2022-2032)

8.1.23. Renin

8.1.23.1. Market Revenue and Forecast (2022-2032)

8.1.24. Lactate Oxidase

8.1.24.1. Market Revenue and Forecast (2022-2032)

8.1.25. Urease

8.1.25.1. Market Revenue and Forecast (2022-2032)

8.1.26. Glutamate Oxidase

8.1.26.1. Market Revenue and Forecast (2022-2032)

8.1.27. Horseradish Peroxide

8.1.27.1. Market Revenue and Forecast (2022-2032)

8.1.28. Others

8.1.28.1. Market Revenue and Forecast (2022-2032)

Chapter 9. Global Diagnostic Enzymes Market, By Application

9.1. Diagnostic Enzymes Market, by Application, 2022-2032

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast (2022-2032)

9.1.2. Diabetes

9.1.2.1. Market Revenue and Forecast (2022-2032)

9.1.3. Infectious Diseases

9.1.3.1. Market Revenue and Forecast (2022-2032)

9.1.4. Cardiology

9.1.4.1. Market Revenue and Forecast (2022-2032)

9.1.5. Autoimmune Diseases

9.1.5.1. Market Revenue and Forecast (2022-2032)

9.1.6. Nephrology

9.1.6.1. Market Revenue and Forecast (2022-2032)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2022-2032)

Chapter 10. Global Diagnostic Enzymes Market, By Product Type 

10.1. Diagnostic Enzymes Market, by Product Type, 2022-2032

10.1.1. Clinical Enzymes

10.1.1.1. Market Revenue and Forecast (2022-2032)

10.1.2. Molecular Enzymes

10.1.2.1. Market Revenue and Forecast (2022-2032)

Chapter 11. Global Diagnostic Enzymes Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2022-2032)

11.1.2. Market Revenue and Forecast, by Application (2022-2032)

11.1.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2022-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2022-2032)

11.1.4.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2022-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2022-2032)

11.1.5.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2022-2032)

11.2.2. Market Revenue and Forecast, by Application (2022-2032)

11.2.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2022-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2022-2032)

11.2.4.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2022-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2022-2032)

11.2.5.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2022-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2022-2032)

11.2.6.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2022-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2022-2032)

11.2.7.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2022-2032)

11.3.2. Market Revenue and Forecast, by Application (2022-2032)

11.3.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2022-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2022-2032)

11.3.4.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2022-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2022-2032)

11.3.5.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2022-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2022-2032)

11.3.6.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2022-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2022-2032)

11.3.7.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2022-2032)

11.4.2. Market Revenue and Forecast, by Application (2022-2032)

11.4.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2022-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2022-2032)

11.4.4.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2022-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2022-2032)

11.4.5.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2022-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2022-2032)

11.4.6.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2022-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2022-2032)

11.4.7.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2022-2032)

11.5.2. Market Revenue and Forecast, by Application (2022-2032)

11.5.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2022-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2022-2032)

11.5.4.3. Market Revenue and Forecast, by Product Type (2022-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2022-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2022-2032)

11.5.5.3. Market Revenue and Forecast, by Product Type (2022-2032)

Chapter 12. Company Profiles

12.1. Sanofi Genzyme

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Codexis Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Aldevron

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F Hoffmann-La Roche Ltd

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Biocatalysts Ltd

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Amano Enzymes

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Kaneka Eurogentec

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Others

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample